Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-09-065690
Filing Date
2009-03-27
Accepted
2009-03-27 13:49:51
Documents
8
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1068565
2 CONSENT OF PRICEWATERHOUSECOOPERS LLP dex231.htm EX-23.1 1316
3 CONSENT OF FLETCHER SPAGHT, INC. dex232.htm EX-23.2 1845
4 CERTIFICATION OF CEO PURSUANT TO SECTION 302 dex311.htm EX-31.1 9104
5 CERTIFICATION OF CFO PURSUANT TO SECTION 302 dex312.htm EX-31.2 9102
6 CERTIFICATION OF CEO PURSUANT TO SECTION 906 dex321.htm EX-32.1 3106
7 CERTIFICATION OF CFO PURSUANT TO SECTION 906 dex322.htm EX-32.2 3078
8 GRAPHIC g31337g93t44.jpg GRAPHIC 67023
  Complete submission text file 0001193125-09-065690.txt   1189936
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Filer) CIK: 0001070336 (see all company filings)

EIN.: 000000000
Type: 10-K | Act: 34 | File No.: 001-33095 | Film No.: 09709424
SIC: 2834 Pharmaceutical Preparations